Relationship between psychostimulant-induced "high" and dopamine transporter occupancy

Proceedings of the National Academy of Sciences of the United States of America

Volumn 93, Issue 19, 1996, Pages 10388-10392

  Volkow, N D ^a,b   Wang, G J ^a   Fowler, J S ^a   Gatley, S J ^a   Ding, Y S ^a   Logan, J ^a   Dewey, S L ^a   Hitzemann, R ^b   Lieberman, J ^c  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c ZUCKER HILLSIDE HOSPITAL   (United States)

Author keywords

Cocaine treatment; Methylphenidate; Positron emission tomography; Reinforcement

Indexed keywords

COCAINE; DOPAMINE RECEPTOR; DOPAMINE UPTAKE INHIBITOR; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE UPTAKE; DRUG DEPENDENCE; HEART RATE; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; REINFORCEMENT; REWARD;

ADULT; ANXIETY; BLOOD PRESSURE; BRAIN; CARBON RADIOISOTOPES; CARRIER PROTEINS; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBELLUM; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; EMOTIONS; HEART RATE; HUMANS; KINETICS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHYLPHENIDATE; NERVE TISSUE PROTEINS; TIME FACTORS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029790269     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.93.19.10388     Document Type: Article

References (21)

1. Rothman, R. B. (1990) Life Sci. 46, 17-21.
2. Ritz, M. C., Lamb, R. J., Goldberg, S. R. & Kuhar, M. J. (1987) Science 237, 1219-1223.
3. Madras, B. K., Fahey, M. A., Bergman, J., Canfield, D. R. & Spealman, R. D. (1989) J. Pharmacol. Exp. Ther. 251, 131-141.
4. Volkow, N. D., Ding, U., Fowler, J. S., Wang, G. J., Logan, J., Gatley, J. S., Dewey, S. L., Ashby, C., Lieberman, J., Hitzemann, R. & Wolf, A. P. (1995) Arch. Gen. Psychiatry 52, 456-463.
5. Johanson C. E. & Schuster, C. R. (1975) J. Pharmacol. Exp. Ther. 193, 676.
6. Bergman, J., Madras, B. K., Johnson, S. E. & Spealman, R. D. (1989) J. Pharmacol. Exp. Ther. 251, 150.
7. Wang, G.-J., Volkow, N. D., Hitzemann, R., Wong, C., Angrist, B., Burr, G., Pascani, K., Pappas, N., Lu, A., Cooper, T. & Lieberman, J. (1996) Eur. Addiction Res., in press.
8. Volkow, N. D., Ding, Y.-S., Fowler, J. S., Wang, G.-J., Logan, J., Gatley, S. J., Schlyer, D. J. & Pappas, N. (1995) J. Nucl. Med. 36, 2162-2168.
9. Logan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R., Hitzemann, R., Bendriem, B., Gatley, J. & Christman, D. R. (1990) J. Cereb. Blood Flow Metab. 10, 740-747.
10. Logan, J., Volkow, N. D., Fowler, J. S., Wang, G.-J, Dewey, S. L., MacGregor, R., Schlyer, D., Gatley, S. J., Pappas, N., King, P., Hitzemann, R. & Vitkun, S. (1994) J. Cereb. Blood Flow Metab. 14, 995-1010.
11. Preston, K. L., Sullivan, J. T., Berger, P. & Bigelow, G. E. (1993) J. Pharmacol. Exp. Ther. 267, 296-307.
12. Stine, S. M., Krystal, J. H., Koster, T. R. & Charney, D. (1995) Drug Alcohol Depend. 39, 245-252.
13. Gawin, F. & Kleber, H. (1985) Am. J. Drug. Alcohol Abuse 11, 193-197.
14. Volkow, N. D., Wang, G.-J., Gatley, S. J., Fowler, J. S., Ding Y.-S., Hitzemann, R., Logan, J., Wong, C. & Lieberman, J. (1996) Psychopharmacology 123, 26-33.
15. Foltin, R. & Fischman, M. W. (1991) J. Pharmacol. Exp. Ther. 257, 247-261.
16. Seeman, P. (1993) Receptor Tables (S. Z. Research, Toronto), Vol. 2.
17. Chait, L. D., Uhlenhuth, E. H. & Johanson, C. E. (1987) J. Pharmacol. Exp. Ther. 242, 777-783.
18. Gawin, F. H. (1986) Psychopharmacology 90, 142-143.
19. Pettit, H. O., Ettenberg, A., Bloom, F. E. & Koob, G. F. (1984) Psychopharmacology 84, 167-173.
20. Izenwasser, S., Werling, L. L. & Cox, B. M. (1990) Brain Res. 520, 303-309.
21. Johanson, C. E. & Fischman, M. W. (1989) Pharmacol. Rev. 41, 3-52.